calendar
10,070 catalysts · 3,350 8k filing · 2,079 grant · 1,097 approval · 1,000 device adverse event · 800 device 510k · 584 earnings
next 91 dayslessmore
MonWedFri
10,070 catalysts · 3,350 8k filing · 2,079 grant · 1,097 approval · 1,000 device adverse event · 800 device 510k · 584 earnings
Sponsor: RISING. Form: CAPSULE, DELAYED RELEASE. Route: ORAL
Sponsor: SOLUBIOMIX. Form: SOLUTION. Route: ORAL
Sponsor: AMNEAL. Form: INJECTABLE. Route: INJECTION
Product code: KDI. Advisory committee: Gastroenterology, Urology. Type: Traditional
Product code: LNH. Advisory committee: Radiology. Type: Traditional
Product code: DPS. Advisory committee: Cardiovascular. Type: Traditional
Supplement type: Normal 180 Day Track. Product code: NCD. Advisory committee: MI. Decision: APPR
Azurion 7 M12 System Model Numbers: (1)722078, (2)722223, (3)722233; Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing
Azurion 7 M20 System Model Numbers: (1)722079, (2)722224, (3)722234, (4)722282(OUS only); Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing
Azurion 7 B12 System Model Numbers:(1) 722067, (2) 722225, (3) 722235; Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing
Azurion 5 M12 System Model Numbers: (1)722227, (2)722231; Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing
Azurion 3 M15 System Model Numbers: (1) 722064, (2) 722222, (3) 722230, (4)722280(OUS only); Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing
Azurion 3 M12 System Model Numbers: (1) 722063, (2) 722221, (3) 722229; Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing
Azurion 7 B20 System Model Numbers: (1)722068, (2)722226, (3)722236; Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing
Azurion 5 M20 System Model Numbers: (1)722228, (2)722232, (3)722281(OUS only); Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing
NS grant. $1,319,674. PI: Prem P Chapagain
NS grant. $234,750. PI: SHAWN HOCHMAN
Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION
Sponsor: MSD MERCK CO. Form: FOR SUSPENSION, DELAYED RELEASE. Route: ORAL
Sponsor: HUMANWELL. Form: TABLET. Route: ORAL
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: TORRENT. Form: TABLET. Route: ORAL
Sponsor: JAZZ PHARMS THERAP. Form: POWDER. Route: INTRAVENOUS
Sponsor: EUGIA PHARMA. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: NATCO. Form: TABLET. Route: ORAL
Sponsor: MANKIND PHARMA. Form: TABLET. Route: ORAL
Sponsor: GLAUKOS. Form: IMPLANT. Route: INTRACAMERAL
Sponsor: GLAUKOS. Form: IMPLANT. Route: INTRACAMERAL
Sponsor: SCHERING. Form: SUSPENSION. Route: ORAL
Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL
Sponsor: GENZYME CORP. Form: TABLET. Route: ORAL
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION
Sponsor: SUN PHARM INDS INC. Form: SUSPENSION. Route: ORAL
Sponsor: MERCK SHARP DOHME. Form: TABLET, DELAYED RELEASE. Route: ORAL
Product code: GEI. Advisory committee: General, Plastic Surgery. Type: Special
Product code: HCG. Advisory committee: Neurology. Type: Special
Product code: GEI. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: LOL. Advisory committee: Microbiology. Type: Traditional
Product code: QAS. Advisory committee: Radiology. Type: Traditional
Supplement type: 30-Day Notice. Product code: NWX. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: MIH. Advisory committee: CV. Decision: OK30
Impella RP Flex with SmartAssist. Product Code: 1000323. — Reason: Differential pressure (dP) sensor in Impella RP devices may malfunction, causing sensor values to drift. — Status: Ongoing
Impella RP with SmartAssist. Product Code: 0046-0035. — Reason: Differential pressure (dP) sensor in Impella RP devices may malfunction, causing sensor values to drift. — Status: Ongoing
Impella RP. Product Code: 0046-0011. — Reason: Differential pressure (dP) sensor in Impella RP devices may malfunction, causing sensor values to drift. — Status: Ongoing
10mL Non-Sterile BD Luer-Lok Tip Syringe Only. Catalog Number: 301029. 850 bulk non-sterile units per case. — Reason: During the bulk packaging process, some Luer Slip syringes were incorrectly included in a batch designated for Luer Lok syringes. — Status: Ongoing
CLARITY II Laser System; Model No. 1110200210. — Reason: Reports of devices sparking/popping and potentially burning patients. — Status: Ongoing
AI grant. $43,914. PI: Adrianna M. Rivera-León
NS grant. $625,859. PI: Rujuta Bhatt Wilson
AI grant. $780,787. PI: Gregoire Stephane Lauvau